Novavax (NVAX) Ratios
Novavax Ratios
MX:NVAX's free cash flow for Q2 2026 was $-74.14M. For the 2026 fiscal year, MX:NVAX's free cash flow was increased by $1.27M and operating cash flow was $-75.41M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.13 | 0.98 | 0.70 | 0.69 | 0.90 |
| Quick Ratio | 2.10 | 0.97 | 0.67 | 0.68 | 0.90 |
| Cash Ratio | 0.52 | 0.46 | 0.35 | 0.54 | 0.63 |
| Solvency Ratio | 0.36 | -0.06 | -0.20 | -0.22 | -0.59 |
| Operating Cash Flow Ratio | -0.53 | -0.08 | -0.44 | -0.17 | 0.14 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -1.28 | 0.00 |
| Net Current Asset Value | $ -325.99M | $ -1.06B | $ -1.37B | $ -1.19B | $ -773.31M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.15 | 0.13 | 0.24 | 0.18 |
| Debt-to-Equity Ratio | -1.95 | -0.37 | -0.32 | -0.87 | -1.29 |
| Debt-to-Capital Ratio | 2.06 | -0.59 | -0.47 | -6.52 | 4.44 |
| Long-Term Debt-to-Capital Ratio | 2.10 | -0.37 | -0.31 | -0.36 | -11.46 |
| Financial Leverage Ratio | -9.21 | -2.50 | -2.51 | -3.56 | -7.33 |
| Debt Service Coverage Ratio | 21.75 | -5.92 | -33.95 | -1.77 | -80.94 |
| Interest Coverage Ratio | 24.98 | -12.40 | -39.30 | -32.43 | -79.83 |
| Debt to Market Cap | 0.22 | 0.14 | 0.35 | 0.61 | 0.03 |
| Interest Debt Per Share | 1.68 | 1.65 | 2.42 | 7.29 | 6.39 |
| Net Debt to EBITDA | 0.02 | 2.77 | 0.70 | 1.30 | 0.63 |
| Profitability Margins | |||||
| Gross Profit Margin | 93.67% | 70.28% | 38.21% | 43.55% | 100.00% |
| EBIT Margin | 41.36% | -22.95% | -95.01% | -39.64% | -857.07% |
| EBITDA Margin | 43.82% | -15.84% | -87.60% | -37.82% | -850.66% |
| Operating Profit Margin | 50.14% | -36.49% | -101.82% | -40.32% | -853.61% |
| Pretax Profit Margin | 39.36% | -25.89% | -97.60% | -40.88% | -867.76% |
| Net Profit Margin | 39.19% | -27.49% | -97.97% | -41.15% | -882.55% |
| Continuous Operations Profit Margin | 39.19% | -27.49% | -97.97% | -41.15% | -882.55% |
| Net Income Per EBT | 99.58% | 106.16% | 100.37% | 100.66% | 101.70% |
| EBT Per EBIT | 78.50% | 70.95% | 95.86% | 101.38% | 101.66% |
| Return on Assets (ROA) | 37.42% | -12.02% | -30.32% | -29.13% | -67.67% |
| Return on Equity (ROE) | -344.65% | 30.06% | 76.03% | 103.76% | 495.84% |
| Return on Capital Employed (ROCE) | 78.61% | -61.31% | -348.94% | 320.34% | -904.65% |
| Return on Invested Capital (ROIC) | 78.00% | -60.27% | -338.23% | -427.51% | -532.10% |
| Return on Tangible Assets | 41.42% | -12.90% | -32.64% | -30.86% | -71.45% |
| Earnings Yield | 40.45% | -15.32% | -112.69% | -81.86% | -16.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.55 | 6.30 | 1.87 | 19.41 | 0.43 |
| Payables Turnover | 2.89 | 4.88 | 2.59 | 4.17 | 0.00 |
| Inventory Turnover | 6.16 | 23.17 | 8.24 | 24.61 | 0.00 |
| Fixed Asset Turnover | 16.60 | 2.27 | 1.13 | 3.99 | 0.86 |
| Asset Turnover | 0.95 | 0.44 | 0.31 | 0.71 | 0.08 |
| Working Capital Turnover Ratio | 4.56 | -2.64 | -0.89 | -3.22 | 0.91 |
| Cash Conversion Cycle | -32.29 | -1.17 | 98.47 | -53.92 | 840.53 |
| Days of Sales Outstanding | 34.58 | 57.94 | 195.00 | 18.80 | 840.53 |
| Days of Inventory Outstanding | 59.23 | 15.75 | 44.27 | 14.83 | 0.00 |
| Days of Payables Outstanding | 126.10 | 74.86 | 140.80 | 87.55 | 0.00 |
| Operating Cycle | 93.82 | 73.69 | 239.27 | 33.64 | 840.53 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.51 | -0.57 | -7.09 | -5.32 | 4.34 |
| Free Cash Flow Per Share | -1.54 | -0.66 | -7.67 | -6.51 | 3.57 |
| Dividend Paid and CapEx Coverage Ratio | -44.00 | -6.68 | -12.14 | -4.47 | 5.62 |
| Capital Expenditure Coverage Ratio | -44.00 | -6.68 | -12.14 | -4.47 | 5.62 |
| Operating Cash Flow Coverage Ratio | -0.98 | -0.38 | -3.12 | -0.76 | 0.71 |
| Operating Cash Flow to Sales Ratio | -0.22 | -0.13 | -1.28 | -0.26 | 1.63 |
| Free Cash Flow Yield | -22.98% | -8.20% | -159.77% | -63.32% | 2.49% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 2.47 | -6.54 | -0.89 | -1.22 | -6.10 |
| Price-to-Sales (P/S) Ratio | 0.97 | 1.79 | 0.87 | 0.50 | 53.87 |
| Price-to-Book (P/B) Ratio | -8.52 | -1.96 | -0.67 | -1.27 | -30.27 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -4.35 | -12.20 | -0.63 | -1.58 | 40.10 |
| Price-to-Operating Cash Flow Ratio | -4.45 | -14.02 | -0.68 | -1.93 | 32.96 |
| Price-to-Earnings Growth (PEG) Ratio | -0.01 | 0.08 | 0.02 | 0.02 | -0.03 |
| Enterprise Value Multiple | 2.23 | -8.55 | -0.30 | -0.03 | -5.70 |
| Enterprise Value | 1.10B | 923.80M | 144.26M | 16.62M | 9.58B |
| EV to EBITDA | 2.23 | -8.55 | -0.30 | -0.03 | -5.70 |
| EV to Sales | 0.98 | 1.35 | 0.26 | 0.01 | 48.50 |
| EV to Free Cash Flow | -4.38 | -9.21 | -0.19 | -0.03 | 36.10 |
| EV to Operating Cash Flow | -4.48 | -10.59 | -0.20 | -0.04 | 29.67 |
| Tangible Book Value Per Share | -1.49 | -4.81 | -8.38 | -9.73 | -6.56 |
| Shareholders’ Equity Per Share | -0.79 | -4.10 | -7.11 | -8.11 | -4.73 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | -0.06 | -0.00 | -0.01 | -0.02 |
| Revenue Per Share | 6.94 | 4.48 | 5.52 | 20.45 | 2.66 |
| Net Income Per Share | 2.72 | -1.23 | -5.41 | -8.42 | -23.44 |
| Tax Burden | 1.00 | 1.06 | 1.00 | 1.01 | 1.02 |
| Interest Burden | 0.95 | 1.13 | 1.03 | 1.03 | 1.01 |
| Research & Development to Revenue | 0.30 | 0.57 | 1.33 | 0.77 | 12.83 |
| SG&A to Revenue | 0.13 | 0.49 | 0.00 | 0.31 | 1.51 |
| Stock-Based Compensation to Revenue | 0.03 | 0.07 | 0.15 | 0.08 | 0.93 |
| Income Quality | -0.56 | 0.47 | 1.31 | 0.63 | -0.19 |
Currency in USD